These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1348921

  • 1. Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients.
    Milroy R, Plumb JA, Batstone P, Maclay A, Wishart GC, Hay FG, Candlish W, Adamson R, Khan MZ, Banham S.
    Anticancer Res; 1992; 12(1):193-200. PubMed ID: 1348921
    [Abstract] [Full Text] [Related]

  • 2. Identification and characterisation in vitro of cells with a non-SCLC cell-like phenotype derived from a continuous SCLC cell line.
    Khan MZ, Freshney RI, Murray AM, Merry S, Plumb JA, McNicol AM.
    Anticancer Res; 1991; 11(5):1687-95. PubMed ID: 1662924
    [Abstract] [Full Text] [Related]

  • 3. Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.
    Berendsen HH, de Leij L, de Vries EG, Mesander G, Mulder NH, de Jong B, Buys CH, Postmus PE, Poppema S, Sluiter HJ.
    Cancer Res; 1988 Dec 01; 48(23):6891-9. PubMed ID: 2846164
    [Abstract] [Full Text] [Related]

  • 4. Detection of multidrug resistance associated P-170 glycoprotein in previously untreated non small cell lung cancer.
    Scagliotti GV, Michelotto F, Kalikatzaros G, Leonardo E, Cappia S, Gubetta L, Borasio P, Pozzi E.
    Anticancer Res; 1991 Dec 01; 11(6):2207-10. PubMed ID: 1685647
    [Abstract] [Full Text] [Related]

  • 5. Establishment and identification of small cell lung cancer cell lines having classic and variant features.
    Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD.
    Cancer Res; 1985 Jun 01; 45(6):2913-23. PubMed ID: 2985257
    [Abstract] [Full Text] [Related]

  • 6. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI.
    Cancer Res; 1990 Sep 15; 50(18):6068-74. PubMed ID: 2168288
    [Abstract] [Full Text] [Related]

  • 7. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
    Arvelo F, Poupon MF, Le Chevalier T.
    Anticancer Res; 1994 Sep 15; 14(5A):1893-901. PubMed ID: 7847823
    [Abstract] [Full Text] [Related]

  • 8. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 15; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 9. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
    Gazdar AF, Carney DN, Nau MM, Minna JD.
    Cancer Res; 1985 Jun 15; 45(6):2924-30. PubMed ID: 2985258
    [Abstract] [Full Text] [Related]

  • 10. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
    Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE, Oie HK, Pass HI, Steinberg SM, Ghosh BC.
    Cancer Res; 1993 Nov 01; 53(21):5181-7. PubMed ID: 8221655
    [Abstract] [Full Text] [Related]

  • 11. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
    Cole SP, Chanda ER, Dicke FP, Gerlach JH, Mirski SE.
    Cancer Res; 1991 Jul 01; 51(13):3345-52. PubMed ID: 1675932
    [Abstract] [Full Text] [Related]

  • 12. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
    Nieuwint AW, Baas F, Wiegant J, Joenje H.
    Cancer Res; 1992 Aug 15; 52(16):4361-71. PubMed ID: 1353703
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterisation of two new small cell lung cancer cell lines--one from a patient with previous familial retinoblastoma.
    Hay FG, Duncan LW, Leonard RC.
    Br J Cancer Suppl; 1991 Jun 15; 14():43-5. PubMed ID: 1645570
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
    Campling BG, Young LC, Baer KA, Lam YM, Deeley RG, Cole SP, Gerlach JH.
    Clin Cancer Res; 1997 Jan 15; 3(1):115-22. PubMed ID: 9815546
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 18. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Huebner K, Croce CM, Pierotti MA.
    Cancer Res; 1997 Dec 01; 57(23):5207-12. PubMed ID: 9393735
    [Abstract] [Full Text] [Related]

  • 19. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p.
    Graziano SL, Cowan BY, Carney DN, Bryke CR, Mitter NS, Johnson BE, Mark GE, Planas AT, Catino JJ, Comis RL.
    Cancer Res; 1987 Apr 15; 47(8):2148-55. PubMed ID: 3030544
    [Abstract] [Full Text] [Related]

  • 20. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.
    Volm M, Mattern J, Efferth T, Pommerenke EW.
    Anticancer Res; 1992 Apr 15; 12(4):1063-7. PubMed ID: 1354430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.